Back to MORGAN STANLEY MORGAN STANLEY

RPRXRPRX
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ROYALTY PHARMA PLC

MORGAN STANLEY holds 42.9M shares of RPRX (ROYALTY PHARMA PLC), worth $2.4B as of 2026-Q2. The position was decreased (-1.5% shares). RPRX represents 0.1% of MORGAN STANLEY's portfolio.

Current Value

$2.4B

Current Shares

42.9M

Total Value Change

+$1.2B

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42.9M
-1.5%
$2.4B0.1%$55.85
0
2026-Q1
Decreased
43.6M
-21.2%
$2.1B0.1%$47.57
0
2025-Q4
Increased
55.3M
+25.2%
$2.1B0.1%$38.12
47
2025-Q3
Decreased
44.2M
-5.2%
$1.6B0.1%$34.61
0
2025-Q2
Increased
46.6M
+13.6%
$1.7B0.1%$35.13
43
2025-Q1
Increased
41M
+3.8%
$1.3B0.1%$30.15
33
2024-Q4
Decreased
39.5M
-3.8%
$1B0.1%$24.55
0
2024-Q3
Decreased
41.1M
-6.9%
$1.2B0.1%$27.00
0

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used